BioNexus Gene Lab Corp. Increase Decrease In Operating Lease Liability
BioNexus Gene Lab Corp. (BGLC) reported Increase Decrease In Operating Lease Liability of -$30.02 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$16.03K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$13.99K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$7.70K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$13.41K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for fiscal 2025 was -$34.51K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for fiscal 2024 was -$42.90K, a 155.98% decline from fiscal 2023.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for fiscal 2023 was $76.62K.
- BioNexus Gene Lab Corp. increase decrease in operating lease liability for fiscal 2022 was -$126.69K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$30.02K 10-Q · filed 2026-08-14 | -$37.72K derived: sum of 3 quarters · filed 2026-08-14 | -$51.13K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$13.99K 10-Q · filed 2026-05-15 | -$21.69K derived: sum of 2 quarters · filed 2026-05-15 | -$35.10K derived: sum of 3 quarters · filed 2026-05-15 | -$38.06K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$7.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$21.11K derived: sum of 2 quarters · filed 2026-04-14 | -$24.07K derived: sum of 3 quarters · filed 2026-08-14 | -$34.51K 10-K · filed 2026-04-14 |
| 2025-09-30 | -$13.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$16.37K derived: sum of 2 quarters · filed 2026-08-14 | -$26.81K 10-Q · filed 2025-11-14 | -$45.36K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$2.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$13.40K 10-Q · filed 2026-08-14 | -$31.95K derived: sum of 3 quarters · filed 2026-08-14 | -$34.03K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$10.44K 10-Q · filed 2026-05-15 | -$29.00K derived: sum of 2 quarters · filed 2026-05-15 | -$31.07K derived: sum of 3 quarters · filed 2026-05-15 | -$41.30K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$18.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$20.63K derived: sum of 2 quarters · filed 2026-04-14 | -$30.85K derived: sum of 3 quarters · filed 2026-04-14 | -$42.90K 10-K · filed 2026-04-14 |
| 2024-09-30 | -$2.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$12.30K derived: sum of 2 quarters · filed 2025-11-14 | -$24.34K 10-Q · filed 2025-11-14 | -$29.71K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$10.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$22.27K 10-Q · filed 2025-08-18 | -$27.64K derived: sum of 3 quarters · filed 2025-08-18 | $65.37K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | -$12.04K 10-Q · filed 2025-05-15 | -$17.41K derived: sum of 2 quarters · filed 2025-05-15 | $75.60K derived: sum of 3 quarters · filed 2025-05-15 | $68.94K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$5.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $87.64K derived: sum of 2 quarters · filed 2025-04-15 | $80.99K derived: sum of 3 quarters · filed 2025-04-15 | $76.62K 10-K · filed 2025-04-15 |
| 2023-09-30 | $93.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $86.36K derived: sum of 2 quarters · filed 2024-11-15 | $81.99K 10-Q · filed 2024-11-15 | -$27.69K derived: sum of 4 quarters · filed 2024-11-15 |
| 2023-06-30 | -$6.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$11.02K 10-Q · filed 2024-08-14 | -$120.70K derived: sum of 3 quarters · filed 2024-08-14 | -$126.52K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$4.37K 10-Q · filed 2024-05-15 | -$114.04K derived: sum of 2 quarters · filed 2024-05-15 | -$119.87K derived: sum of 3 quarters · filed 2024-05-15 | -$126.05K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$109.68K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$115.50K derived: sum of 2 quarters · filed 2024-04-16 | -$121.68K derived: sum of 3 quarters · filed 2024-04-16 | -$126.69K 10-K · filed 2024-04-16 |
| 2022-09-30 | -$5.83K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | -$12.00K derived: sum of 2 quarters · filed 2024-03-26 | -$17.01K 10-Q/A · filed 2024-03-26 | -$21.34K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | -$6.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$11.18K 10-Q · filed 2023-08-16 | -$15.52K derived: sum of 3 quarters · filed 2023-08-16 | -$20.43K derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | -$5.01K 10-Q · filed 2023-05-09 | -$9.34K derived: sum of 2 quarters · filed 2023-05-09 | -$14.26K derived: sum of 3 quarters · filed 2023-05-09 | -$18.80K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$4.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.25K derived: sum of 2 quarters · filed 2023-03-31 | -$13.79K derived: sum of 3 quarters · filed 2023-03-31 | -$20.17K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$4.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$9.46K derived: sum of 2 quarters · filed 2022-11-14 | -$15.84K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$4.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$10.92K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$6.38K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |